rundown roicam copy
TRANSCRIPT
8R ICAM THE ROLE OF INTERNIST IN CANCER MANAGEMENT
OVERCOMINGCHALLENGES IN
RUNDOWN
MANAGEMENTJUNE 12 th - JULY 4 th 2021
CANCER
SYMPOSIUM DAY 1 (Saturday, June 12nd , 2021)
The Role of Internist in Cancer ManagementR ICAM 8
Overcoming Challenges in Cancer Management
OPENING CEREMONYTIME TOPIC
07.00 - 07.30 REGISTRATION
07.30 - 07.45Patient Safety and Ethics
Prof. dr. Zubairi Djoerban, SpPD, K-HOM, FINASIM
07.45 - 08.15
OPENING CEREMONYDr. dr. Hilman Tadjoedin, SpPD, K-HOM
(Chairman of National Congress and Symposium of ROICAM 8, 2021)
Dr. dr. TB. Djumhana Atmakusuma, SpPD, K-HOM(Chairman of PERHOMPEDIN/ISHMO)
Prof. Dr. dr. Aru Wisaksono Sudoyo, SpPD, K-HOM, FINASIM, FACP(Chairman of POI)
dr. Sally A. Nasution, SpPD, K-KV(Chairman of PAPDI/ISIM)
- PLENARY WEBINAR 1 -NEW TREATMENT OF HEMATOLOGIC MALIGNANCIES : FOCUS ON LENALIDOMIDE
TIME TOPIC
09.00 - 09.05 Moderator
dr. Nyoto Widyo Astoro, SpPD-KHOM
09.05 - 09.20Role of Multiple Myeloma Treatmentdr. Sugiyono Somoastro, SpPD, K-HOM
09.20 - 09.35An Update Treatment of Mantel Cell Lymphomadr. Nadia Ayu Mulansari, SpPD, K-HOM, FINASIM
09.35 - 09.50New Horizon of Myelodysplastic Syndrome Treatment
dr. Resti Mulya Sari, SpPD, K-HOM, FINASIM
09.50 - 10.00 Discussion
PARALEL WEBINAR 1 -SUPPORTIVE TREATMENT : FOCUS ON
PAIN MANAGEMENT
PARALEL WEBINAR 2 -HEMATOLOGIC DISORDER
TIME TOPIC TOPIC
13.00 - 13.05 Moderator
Prof. dr. Zubairi Djoerban, SpPD, K-HOM, FINASIMModerator
dr. Prasetyo Widhi Buwono, SpPD, K-HOM
13.05 - 13.20Pain Assessment
dr. Asrul Harsal, SpPD, K-HOM, FINASIMPolycythemia Vera in Daily Practicedr. Rahmat Cahyanur, SpPD, K-HOM
13.20 - 13.35How to Treat Pain in Cancer Patient
dr. Diana Paramita, SpPD, K-HOMMyelofibrosis : Diagnostic Problems
Dr. dr. Lugyanti Sukrisman, SpPD, K-HOM, FINASIM
13.35 - 13.50Opioids Used in Cancer Patients
dr. Resti Mulya Sari, SpPD, K-HOM, FINASIMManagement of Myeloproliferative Neoplasms
dr. Toman L Toruan, SpPD, K-HOM
13.50 - 14.00 Q&A Q&A
14.00 - 14.05 Summary and closing by moderator Summary and closing by moderator
SYMPOSIUM DAY 2 (Sunday, June 13rd , 2021)
The Role of Internist in Cancer ManagementR ICAM 8
Overcoming Challenges in Cancer Management
- PLENARY WEBINAR 2 -IMMUNOTHERAPHY IN VARIOUS MALIGNANCIES
TIME TOPIC
09.00 - 09.05Moderator
Dr. dr. TB. Djumhana Atmakusuma, SpPD, K-HOM
09.05 - 09.20Immunotherapy as Standard of Care In Metastatic NSCLC
Dr. dr. Andhika Rachman, SpPD, K-HOM, FINASIM
09.20 - 09.35Immunotherapy for Recurrent and Metastatic Head and Neck Cancer
Dr. dr. Noorwati Sutandyo, SpPD, K-HOM, FINASIM
09.35 - 09.50The Role of Immunotherapy in Melanoma Maligna
dr. T. Heri Fadjari, SpPD, K-HOM
09.50 - 10.00 Discussion
PARALEL WEBINAR 3 -THE ROLE OF TARGETED THERAPY IN
HEAD-NECK AND COLON CANCER
PARALEL WEBINAR 4 -CAR-T CELL THERAPY: NEW HOPE FOR
LYMPHOMA PATIENT
TIME TOPIC TOPIC
13.00 - 13.05 Moderator
dr. Marthin Batubara, SpPD, K-HOM Moderator
Prof. Dr. dr. A. Harryanto Reksodiputro, SpPD, K-HOM, FINASIM
13.05 - 13.20 Clinical Updates in DLBCL – Advent of CAR-T Cell TherapyProf. YL Kwong
(International Speaker-Hongkong)
13.20 - 13.35
Pathway of targeted therapy to Cure Cancerdr. Eka Widya Khorinal, SpPD, K-HOM, FINASIM
Colon Cancer : The Role of Targeted TherapyProf. Dr. dr. Aru Wisaksono Sudoyo, SpPD, K-HOM,
FINASIM, FACP
Targeted Therapy for Head and NeckCancer Treatment
dr. Wulyo Rajabto, SpPD, K-HOM
Q&A
Summary and closing by moderator Summary and closing by moderator
Q&A
Practical Consideration for Optimal DLBCL PatientManagement with CAR-T Cell Therapy
Prof. William Hwang (International Speaker- Singapore)13.35 - 13.50
13.50 - 14.00
14.00 - 14.05
SYMPOSIUM DAY 3 (Saturday, June 19th , 2021)
The Role of Internist in Cancer ManagementR ICAM 8
Overcoming Challenges in Cancer Management
- PLENARY WEBINAR 3 -IIMMUNOTHERAPY : WHAT ARE THE CLINICAL IMPLICATIONS FOR CANCER PATIENTS?
TIME TOPIC
09.00 - 09.05Moderator
Prof. dr. Abdul Muthalib, SpPD, K-HOM, FINASIM
09.05 - 09.20Liver cancer: Daily practice and changing treatment paradigm
Prof. Toh Han Chong (International Speaker-Singapore)
09.20 - 09.35Lung cancer: What's New in Lung Cancer Treatment with Cancer Immunotherapy?
dr. Pongwut Danchaivijitr (International Speaker-Thailand)
09.35 - 09.50Safety profile and real case experience
Dr. dr. Ikhwan Rinaldi, SpPD, K-HOM, M. Epid, MPd.Ked, FINASIM, FACP
09.50 - 10.00 Discussion
PARALEL WEBINAR 5 -MULTIVITAMIN & ANTIOXIDANT IN
CANCER THERAPY
PARALEL WEBINAR 6 -BIOSIMILARS DRUGS
TIME TOPIC TOPIC
13.00 - 13.05 Moderator
Dr. dr. Nugroho Prayogo, SpPD, K-HOM, FINASIMModerator
Prof. dr. Zubairi Djoerban, SpPD, K-HOM, FINASIM
13.05 - 13.20Immunogenecity, Switching and Extrapolation in
Oncology Biosimilarsapt. Dr. Dra. Rizka Andalusia, M.Pharm, MARS
13.20 - 13.35
The Role of Epigalocatechin Gallate inCancer Therapy
dr. Faizal Drissa Hasibuan , SpPD, K-HOM
Parenteral Vitamins and It’s Role inCancer Therapy
Dr. Rahmat Cahyanur, Sp. PD, K-HOM
Biosimilars Use in Clinical PracticeDr. dr. Hilman Tadjoedin, SpPD, K-HOM
Exercise and Food to Reduce Cancer RiskDr. Prasetyo Widhi Buwono, Sp. PD, K-HOM
Cost-Effectiveness of Biosimilars in Daily PracticeDr. Inolyn Panjaitan, SpPD, K-HOM
Q&A
Summary and closing by moderator Summary and closing by moderator
Q&A
13.35 - 13.50
13.50 - 14.00
14.00 - 14.05
SYMPOSIUM DAY 4 (Sunday, June 20th , 2021)
The Role of Internist in Cancer ManagementR ICAM 8
Overcoming Challenges in Cancer Management
- PLENARY WEBINAR 4 -LUNG CANCER ALK+
TIME TOPIC
09.00 - 09.05 Moderator
Prof. Dr. dr. A. Harryanto Reksodiputro, SpPD, K-HOM, FINASIM
09.05 - 09.20Diagnosis Approach of NSCLC ALK+
dr. Asrul Harsal, SpPD, K-HOM, FINASIM
09.20 - 09.35Treatment Strategy in NSCLC ALK+ and It’s Unmet Need
dr. Nadia Ayu Mulansari, SpPD, K-HOM, FINASIM
09.35 - 09.50New Treatment Landscape in NSCLC ALK+
dr. Ronald A. Hukom, MHSc, SpPD, K-HOM, FINASIM
09.50 - 10.00 Discussion
PARALEL WEBINAR 7 -MULTIPLE MYELOMA
PARALEL WEBINAR 8 -PREVENTION OF THROMBOSIS
IN CANCER
TIME TOPIC TOPIC
13.00 - 13.05 Moderator
dr. Bambang Karsono, SpPD, K-HOM`
ModeratorProf. dr. C. Suharti, SpPD, K-HOM, Ph.D, FINASIM
13.05 - 13.20Cancer and Hypercoagulation
Prof. dr. Rahajuningsih Dharma Setiabudy, Sp.PK(K), Dsc, FACT
13.20 - 13.35
Diagnostic Approach of Multiple MyelomaDr. dr. Agus Kosasih, Sp. PK, MARS
Navigating clinical advances in Multiple Myeloma:Does stem cell transplant still have a role?
dr. Sri Agustini Kurniawati, SpPD, K-HOM, FINASIM
Identification and Balancing of Thrombosis in Cancerdr. Ralph Girson Manuel, SpPD, K-HOM
Spotlight on Amyloidosis - What we needto know?
Prof. Dr. dr. Ami Ashariati, SpPD, K-HOM
Risk of Bleeding and Thrombosis in High-Risk PatientsDr. dr. Cosphiadi Irawan, SpPD, K-HOM, FINASIM
Q&A
Summary and closing by moderator Summary and closing by moderator
Q&A
13.35 - 13.50
13.50 - 14.00
14.00 - 14.05
SYMPOSIUM DAY 5 (Saturday, June 26th , 2021)
The Role of Internist in Cancer ManagementR ICAM 8
Overcoming Challenges in Cancer Management
- PLENARY WEBINAR 5 -INDOLENT LYMPHOMA
TIME TOPIC
09.00 - 09.05 Moderator
Prof. dr. Nuzirwan Acang, SpPD, K-HOM, FINASIM
09.05 - 09.20Follicular Lymphoma: Are We Ready for a Risk-Adapted Approach?
dr. Johan Kurnianda, SpPD, K-HOM
09.20 - 09.35Towards Personalized Treatment in Waldenström MacroglobulinemiaDr. dr. Ikhwan Rinaldi, SpPD, K-HOM, M. Epid, MPd.Ked, FINASIM, FACP
09.35 - 09.50Improved Biological Insight and Influence on Management in Indolent Lymphoma
Dr. dr. Dody Ranuhardy, SpPD, K-HOM, MPH, FINASIM
09.50 - 10.00 Discussion
PARALEL WEBINAR 9 -GASTRIC CANCER
PARALEL WEBINAR 10 -GCSF IN NEUTROPENIA INDUCED
BY CHEMOTHERAPY
TIME TOPIC TOPIC
13.00 - 13.05 Moderator
Prof. Dr. dr. Aru Wisaksono Sudoyo, SpPD, K-HOM,FINASIM, FACP
Current Gastric Cancer Management.Clinical experience and perspective
Prof Kensei Yamaguci(International Speaker - Jepang)
ModeratorDr. dr. Dody Ranuhardy, SpPD, K-HOM, MPH, FINASIM
13.05 - 13.20Supportive care with GCSF for chemotherapy
induced neutropeniadr. Diah Ari Savitri, SpPD, K-HOM
13.20 - 13.35Choose the right option: Short acting or long
acting GCSF?dr. Sri Agustini Kurniawati, SpPD, K-HOM, FINASIM
Oral fluoropyrimidine in Gastric Cancer: fulfillthe Unmet Needs?
dr. Eka Widya Khorinal, SpPD, K-HOM, FINASIM
Biosimilar Pegfilgrastim: a pathway to look atdr. Jeffrey Beta Tenggara, SpPD, K-HOM
Q&A
Summary and closing by moderator Summary and closing by moderator
Q&A
13.35 - 13.50
13.50 - 14.00
14.00 - 14.05
SYMPOSIUM DAY 6 (Sunday, June 27th , 2021)
The Role of Internist in Cancer ManagementR ICAM 8
Overcoming Challenges in Cancer Management
- PLENARY WEBINAR 6 -MANAGEMENT THERAPY OF HIGH PREVALANCE CANCER IN INDONESIA FOCUS ON
BREAST CANCER (BC) AND LUNG CANCER (LC)
TIME TOPIC
09.00 - 09.05 Moderator
dr. Mediarty Syahrir, SpPD, K-HOM
09.05 - 09.20Holistic approach in the hormonal management of breast cancer
dr. Anna Mira Lubis, SpPD, K-HOM, FINASIM
09.20 - 09.35New Paradigm: Extending Survival in Stage III NSCLC
Dr. dr. H. Rachmat Sumantri, SpPD, K-HOM
09.35 - 09.50Managing EGFR Mutant NSCLC : Paving the way to better outcome
Dr. dr. Noorwati Sutandyo, SpPD, K-HOM, FINASIM
09.50 - 10.00 Discussion
PARALEL WEBINAR 11 -CHRONIC MYELOGENOUS LEUKEMIA
(CML)
PARALEL WEBINAR 12 -CURRENT UPDATE ON CHRONIC IMMUNE
THROMBOCYTOPENIA (ITP) MANAGEMENT
TIME TOPIC TOPIC
13.00 - 13.05 Moderator
Prof. dr. Linda Rotty, SpPD, K-HOM, FINASIM
Diagnostic CMLdr. Sugiyono Somoastro, SpPD, K-HOM
Moderatordr. Syafrizal Syafei, SpPD, K-HOM
13.05 - 13.20Overview & Pathophysiology of ITPdr. Findy Prasetyawati, SpPD, K-HOM
13.20 - 13.35 Clinical experienceDr. dr. Hilman Tadjoedin, SpPD, K-HOM
How to Diagnose ITP?dr. Anna Mira Lubis, SpPD, K-HOM, FINASIM
Therapy on CMLdr. Intan Russianna Nasution , SpPD, K-HOM
Management of Chronic ITP – The Role of Eltombropagdr. Edison Y.P Saragih, SpPD, K-HOM
Q&A
Summary and closing by moderator Summary and closing by moderator
Q&A
13.35 - 13.50
13.50 - 14.00
14.00 - 14.05
SYMPOSIUM DAY 7 (Saturday, July 3rd , 2021)
The Role of Internist in Cancer ManagementR ICAM 8
Overcoming Challenges in Cancer Management
- PLENARY WEBINAR 7 -REIMAGINING MANAGEMENT OF PREMENOPAUSAL BREAST CANCER
TIME TOPIC
09.00 - 09.05 Moderator
dr. Ronald A. Hukom, MHSc, SpPD, K-HOM, FINASIM
09.05 - 09.20Surgical management in premenopausal breast cancer
Dr. dr. Sonar Soni Panigoro, Sp.B(K)Onk, M.Epid, MARS
09.20 - 09.35What’s new in systemic treatment of premenopausal advanced breast cancer
Dr. dr. Cosphiadi Irawan, SpPD, K-HOM, FINASIM
09.35 - 09.50Overall survival with endocrine-based CDK4/6i treatment in premenopausal
advanced breast cancerProf Lu Yen-Shen
(International Speaker – Taiwan)
09.50 - 10.00 Discussion
- PLENARY WEBINAR 8 -EVOLVING THERAPEUTIC STANDARDS IN HR(+)/HER2(-) ADVANCED BREAST CANCER
TIME TOPIC
13.00 – 13.05 Moderator
Prof. dr. Abdul Muthalib, SpPD, K-HOM, FINASIM
13.05 – 13.30 Measuring recent progress of HR +/ HER2 – mBC treatment
Dr. dr. Andhika Rachman, SpPD, K-HOM, FINASIM
13.30 – 13.50 Establishing the right care at the right time for HR +/ HER2 – mBC:
Considerations for Treatment ChoiceProf. Giuseppe Curigliano (International Speaker – Italia)
13.50 – 14.00 Discussion
SYMPOSIUM DAY 8 (Sunday, July 4th , 2021)
The Role of Internist in Cancer ManagementR ICAM 8
Overcoming Challenges in Cancer Management
- PLENARY WEBINAR 9 -HOLISTIC THERAPY IN CANCER TREATMENT
CLOSING CEREMONY
TIME
TIME
TOPIC
TOPIC
09.00 - 09.05Moderator
Dr. dr. Andi Fachruddin Benyamin, SpPD, K-HOM
09.05 - 09.20 Role of HER 2+ in Breast Cancer Treatment dr. Wulyo Rajabto, SpPD, K-HOM
09.20 - 09.35How to treat Triple – in BC
dr. Bambang Karsono, SpPD, K-HOM
HR+ HER2- BC : New Drug OptionShaheenah Dawood, MD, MBBCh, FRCP (Glasgow), FRCP (Edin), FACP, MPH
(International Speaker – Dubai)
Closing Remarks from Chairman of ROICAM 8
Dr. dr. Hilman Tadjoedin, SpPD, K-HOM
CLOSING CEREMONY
Doorprize Winners Announcement
09.35 - 10.05
10.10 - 10.30
10.05 - 10.10 Discussion
WORKSHOP
The Role of Internist in Cancer ManagementR ICAM 8
Overcoming Challenges in Cancer Management
TIME PROGRAM
08.00 – 08.30 Registration
08.30 – 08.45
08.45 – 09.15
09.15 – 09.45
Pretest Moderator :Dr. dr. Nugroho Prayogo, SpPD, K-HOM, FINASIM
The Role of Chemotherapy : Mechanism of Action & Side Effectdr. Rajesh Kalwani, SpPD-KHOM
What is Chemotherapy?dr. Femiko MN Sitohang, SpPD-KHOM
09.45 – 10.15 Various Problems and Case Sharingdr. Toman L Toruan, SpPD, K-HOM
10.15 – 10.30 Discussion
10.30 – 10.45 Post-test
TIME PROGRAM
12.30 - 13.00 Registration
13.00 – 13.15
13.15 – 13.45
Pretestmoderator : dr. Syafrizal Syafei, SpPD, K-HOM
Diagnosis of Infection in Malignant Patients dr. Jusi Susilawati, SpPD-KHOM
13.45 – 14.15 Management of Fungal Infection and Case Sharingdr. Marthino Robinson, SpPD-KHOM
14.15 – 14.45 Management of Bacterial Infection and Case Sharing Dr. dr. Hilman Tadjoedin, SpPD, K-HOM
14.45 – 15.00 Discussion
15.00 – 15.15 Post-test
WORKSHOP 1: CHEMOTHERAPY (Friday, July 2nd, 2021)
WORKSHOP 2: INFECTIONS (Friday, July 2nd, 2021)
TIME PROGRAM
12.30 - 13.00 Registration
13.00 – 13.15
13.15 – 13.45
Pretestmoderator : Prof. Dr. dr. Aru Wisaksono Sudoyo, SpPD, K-HOM, FINASIM, FACP
Patophysiology coagulopathy in covidDr. dr. Lugyanti Sukrisman, SpPD, K-HOM, FINASIM
13.45 – 14.15 Therapy of Coagulopathy in Covid and Cancer Dr. dr. TB. Djumhana Atmakusuma, SpPD, K-HOM
14.15 – 14.45
14.45 – 15.00
Case sharingdr. Griskalia Christine, SpPD-KHOM
15.00 – 15.15 Post-test
Discussion
WORKSHOP 3: THROMBOSIS (Sunday, July 4th , 2021)